Ekso Bionics Holdings, Inc. financial data

Symbol
EKSO on Nasdaq
Location
101 Glacier Point, Suite A, San Rafael, CA
State of incorporation
NV
Fiscal year end
December 31
Former names
PN Med Group Inc (to 12/31/2013)
Latest financial report
10-K - Q4 2024 - Mar 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 263 % -1.27%
Quick Ratio 65.5 % +6.98%
Debt-to-equity 108 % +12.8%
Return On Equity -84.4 % +7.03%
Return On Assets -40.5 % +12.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 24.8M shares +36.6%
Common Stock, Shares, Outstanding 22.2M shares +49.5%
Entity Public Float 18.8M USD +0.3%
Common Stock, Value, Issued 22K USD +46.7%
Weighted Average Number of Shares Outstanding, Basic 20.2M shares +45.4%
Weighted Average Number of Shares Outstanding, Diluted 20.2M shares +45.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.87M USD -22.9%
Selling and Marketing Expense 7.31M USD -13.7%
General and Administrative Expense 8.79M USD -17.8%
Operating Income (Loss) -10.5M USD +30.8%
Nonoperating Income (Expense) -870K USD -912%
Net Income (Loss) Attributable to Parent -11.3M USD +25.5%
Earnings Per Share, Basic -0.56 USD/shares +49.1%
Earnings Per Share, Diluted -0.65 USD/shares +42%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.49M USD -24.8%
Accounts Receivable, after Allowance for Credit Loss, Current 7.24M USD +28.2%
Inventory, Net 4.57M USD -9.49%
Assets, Current 18.8M USD -6.76%
Property, Plant and Equipment, Net 1.58M USD -21.9%
Operating Lease, Right-of-Use Asset 788K USD -19.3%
Intangible Assets, Net (Excluding Goodwill) 4.58M USD -6.38%
Goodwill 431K USD 0%
Other Assets, Noncurrent 433K USD +10.5%
Assets 26.7M USD -7.84%
Accounts Payable, Current 1.55M USD -16%
Employee-related Liabilities, Current 1.68M USD -18.2%
Accrued Liabilities, Current 2.35M USD -11.7%
Contract with Customer, Liability, Current 1.96M USD -1.86%
Liabilities, Current 7.54M USD -7.15%
Contract with Customer, Liability, Noncurrent 1.92M USD -11.5%
Operating Lease, Liability, Noncurrent 452K USD -37.5%
Other Liabilities, Noncurrent 181K USD +72.4%
Liabilities 13.9M USD -14.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 957K USD +513%
Retained Earnings (Accumulated Deficit) -250M USD -4.74%
Stockholders' Equity Attributable to Parent 12.7M USD +0.8%
Liabilities and Equity 26.7M USD -7.84%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.47M USD +17.8%
Net Cash Provided by (Used in) Financing Activities 3.66M USD
Net Cash Provided by (Used in) Investing Activities -8K USD +81%
Common Stock, Shares Authorized 141M shares 0%
Common Stock, Shares, Issued 22.2M shares +49.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 161K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.49M USD -24.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 48K USD +2.13%
Deferred Tax Assets, Valuation Allowance 59.8M USD +2.67%
Operating Lease, Liability 879K USD -19.1%
Depreciation 414K USD +79.2%
Payments to Acquire Property, Plant, and Equipment 8K USD -81%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.5M USD +32.5%
Lessee, Operating Lease, Liability, to be Paid 953K USD -21.6%
Property, Plant and Equipment, Gross 4.92M USD -4.95%
Operating Lease, Liability, Current 427K USD +17.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 431K USD +3.36%
Lessee, Operating Lease, Liability, to be Paid, Year One 481K USD +10.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 74K USD -43.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 41K USD -88.7%
Deferred Tax Assets, Operating Loss Carryforwards 54M USD +2.96%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.84M USD -3.06%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Additional Paid in Capital 262M USD +4.22%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 406K USD -1.93%
Share-based Payment Arrangement, Expense 1.37M USD -26.1%
Interest Expense 247K USD +2.49%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%